Romel Montellano
About Romel Montellano
Romel Montellano serves as the Senior Director of Regulatory Operations at Mirati Therapeutics, a position he has held since 2021. He has extensive experience in regulatory affairs, having worked in various roles across multiple pharmaceutical companies over two decades.
Work at Mirati Therapeutics
Romel Montellano has held the position of Senior Director, Regulatory Operations at Mirati Therapeutics since 2021. In this role, he oversees regulatory strategies and ensures compliance with industry standards. Prior to this position, he served as Director of Regulatory Operations at Mirati from 2017 to 2021, contributing to the company's regulatory initiatives and operational efficiency.
Previous Experience in Regulatory Affairs
Romel Montellano has extensive experience in regulatory affairs, having worked at several pharmaceutical companies. He began his career at Quintiles as an Associate in Regulatory Affairs from 2001 to 2002. He then worked at Elan Pharmaceuticals in various roles, including Senior Associate and Associate in Regulatory Affairs from 2004 to 2005 and 2002 to 2004, respectively. His experience also includes positions at Neurocrine Biosciences and Halozyme Therapeutics, where he held roles such as Associate Director and Senior Manager in Regulatory Operations and Affairs.
Educational Background
Romel Montellano holds a Master of Business Administration (M.B.A.) from San Diego State University. He also earned a Bachelor's degree in Psychology from the University of California, San Diego. Additionally, he achieved a Professional Certificate in Regulatory Affairs for the Biomedical Industry from the University of California San Diego - School of Extended Studies and Public Programs.
Career Progression in Regulatory Operations
Montellano's career in regulatory operations includes significant roles at various organizations. He worked at Halozyme Therapeutics in multiple capacities, including Senior Publication Specialist and Senior Manager of Regulatory Affairs from 2008 to 2014. He also served as Associate Director of Regulatory Operations at both Halozyme and Neothetics. His experience spans over two decades, showcasing a consistent focus on regulatory compliance and operational management.